Remove topics waivers
article thumbnail

An Obituary to the TRIPS ‘Waiver’: Lessons from an Imperfect Response 

SpicyIP

While the spike should not be a cause of concern owing to a proper vaccination run (also see here for the number of doses administered), elsewhere, experts and delegates are still engaged in negotiations over a possible extension of the TRIPS waiver to medical supplies and pharmaceuticals products.

Licensing 143
article thumbnail

Inviting Applications for the SpicyIP Doctoral Fellowship!

SpicyIP

Any other scholarship or fellowship or fee waiver currently present including those funded by public or private organisations, along with a copy of the terms of such scholarship or fellowship or fee waiver. Any conflict of interests to be declared regarding research topic, or anything else that may be relevant for the Fellowship.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

[Podcast] Onshoring Drug Manufacturing and TRIPS Waiver Part II

JD Supra Law

Among the topics covered: - The TRIPS waiver and vaccines. Mario Ramirez welcome Akin Gump public law and policy partner Clete Willems and Centrient Pharmaceuticals chief legal and compliance officer Jim DeYonker. Global supply chains. Onshoring drug manufacturing. Enforcing IP outside the U.S.

IP 98
article thumbnail

[Sponsored] LexisNexis to Celebrate World IP Day with Daily Webinars

SpicyIP

As a forward-thinking organization, the role IP plays in fostering fair and responsible innovation for all—and how it cultivates the spirit of innovation in the next generation—are key topics for our team at LexisNexis Intellectual Property Solutions. April 26 – What You Can Learn from the World’s Leading Innovators.

IP 105
article thumbnail

Tillis Addresses Criticism of His Eligibility Reform Bill, Warns WD of TX Not to Backtrack on Standing Order

IP Watchdog

Patent and Trademark Office (USPTO) on topics such as patent quality and has written numerous letters to the Biden Administration on issues including the waiver of IP obligations under the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement, the theft of U.S. Prometheus Laboratories, Inc., 1289 (2012).

article thumbnail

Monday Miscellany

The IPKat

University of Nottingham - Vaccine access and Covid waiver in light of overlapping commitments outside TRIPS - 23 March 2022 There are severe inequalities for access to vaccines and other health technologies for the prevention, treatment, or containment of Covid-19 around the world. More information about the event is available here.

article thumbnail

AIPPI Congress (Report 1): Is IP the "bogeyman" in access to Covid-19 vaccines?

The IPKat

This is the first in-person Congress since London hosted in 2019, so it was only apt that the first panel session was on the topic of IP and Covid-19. The debate that surrounded the waiver proposal kept (and keeps) WTO busy and culminated on 17 June 20222 at the WTO Ministerial Conference.